Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6541
    +0.0018 (+0.28%)
     
  • OIL

    84.13
    +0.56 (+0.67%)
     
  • GOLD

    2,358.20
    +15.70 (+0.67%)
     
  • Bitcoin AUD

    98,087.11
    +370.10 (+0.38%)
     
  • CMC Crypto 200

    1,384.23
    -12.30 (-0.88%)
     
  • AUD/EUR

    0.6098
    +0.0025 (+0.41%)
     
  • AUD/NZD

    1.0987
    +0.0030 (+0.27%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,119.89
    +41.03 (+0.51%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    18,059.85
    +142.57 (+0.80%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

This Exciting Biotech Stock Could Be Your Next 10-Bagger

The stock performance of 23andMe (NASDAQ: ME) has plunged since it went public last June. But, in this video clip from "The Rank" on Motley Fool Live, recorded on March 28, Fool.com contributors Matt Frankel and Travis Hoium discuss a few of the biotech company's promising business plans that could pay off in a big way over the next few years.